Lishengpharma(SZ:002393) Sou Hu Cai Jing·2025-11-09 19:18Core Viewpoint - The company, Lifesun Pharmaceutical (002393), is focusing on balancing shareholder returns with business development, emphasizing the importance of sharing growth benefits with investors [2]. Group 1: Stock Performance - As of November 7, 2025, Lifesun Pharmaceutical's stock closed at 21.67 yuan, with a slight increase of 0.28% [1]. - The trading volume was 24,800 shares, resulting in a transaction amount of 53.79 million yuan [1]. Group 2: Investor Relations - An investor expressed concerns regarding the company's dividend policy, suggesting that the company should distribute more dividends to attract long-term investors like social security funds and insurance capital [2]. - The company’s secretary acknowledged the investor's feedback, stating that the current dividend policy aims to balance business growth and shareholder returns, taking into account industry characteristics, profitability, and cash flow [2]. Group 3: Market Sentiment - On November 7, there was a net outflow of 1.58 million yuan from institutional investors, while retail investors saw a net inflow of 2.78 million yuan, indicating a divergence in short-term trading sentiment [3]. - Retail investors experienced a net outflow of 1.20 million yuan on the same day [3].